Follow
Harvijay Singh, Ph.D.
Harvijay Singh, Ph.D.
Senior Scientist at Zoetis, Inc. MI, USA
Verified email at zoetis.com - Homepage
Title
Cited by
Cited by
Year
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
Y Kumar, H Singh, CN Patel
Journal of infection and public health 13 (9), 1210-1223, 2020
2252020
Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site
H Singh, M Narwal, S Pratap, A Malik, RJ Kuhn, P Kumar, S Tomar
International journal of biological macromolecules 116, 451-462, 2018
582018
Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease
H Singh, R Mudgal, M Narwal, R Kaur, VA Singh, A Malik, M Chaudhary, ...
Biochimie 149, 51-61, 2018
562018
In silico identification and docking-based drug repurposing against the main protease of SARS-CoV-2, causative agent of COVID-19
Y Kumar, H Singh
222020
Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease
S Dhindwal, P Kesari, H Singh, P Kumar, S Tomar
Journal of Biomolecular Structure and Dynamics 35 (16), 3522-3539, 2017
192017
Biochemical and biophysical insights into the metal binding spectrum and bioactivity of arginase of Entamoeba histolytica
A Malik, H Singh, A Pareek, S Tomar
Metallomics 10 (4), 623-638, 2018
72018
Techniques for the Isolation of Plant-Based Bioactive Compounds
A Malik, H Singh
Isolation, Characterization, and Therapeutic Applications of Natural …, 2022
2022
Chikungunya Virus Protease Inhibitors and uses thereof.
MR Tomar S., Kumar P., Singh H.
IN Patent Application no. 201,811,022,065, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–8